¸¸¼º BÇü°£¿° Ä¡·áÀÇ ÃֽŠÁö°ß: 2018 ´ëÇÑ°£ÇÐȸ Áø·á °¡À̵å¶óÀÎÀ» Áß½ÉÀ¸·Î
Updated Treatment of Chronic Hepatitis B
À±¾ÆÀϸ°, ÀÓÇüÁØ,
¼Ò¼Ó »ó¼¼Á¤º¸
À±¾ÆÀϸ° ( Yoon Eileen L. )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¼Òȱ⳻°ú
ÀÓÇüÁØ ( Yim Hyung-Joon )
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¾È»êº´¿ø ¼Òȱ⳻°ú
Abstract
Chronic hepatitis B virus (HBV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma in Korea. The prevalence of HBV infection is gradually decreasing in Korea, but 3.0% of the total population still suffers from HBV- related chronic liver diseases. In this review, we summarize the updated clinical practice guideline for management of chronic hepatitis B, as revised by the Korean Association for the Study of the Liver in 2018.
Å°¿öµå
Hepatitis B, Chronic; Guidelines; Therapeutics
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸